Clarinol[TM] conjugated linoleic acid (CLA). (Raw Material Research).
Source: NIH Conference, May 2002
Research: Using the hepatitis B vaccination as an infection model, 75 human subjects were divided into three treatment groups that were supplemented for a 13 week period. The groups included a control group and two CLA groups that received two different ratios of the naturally occurring isomers c9,t11 and t10, c12--one group at the ratio of 50:50 and the other group at the ratio of 80:20.
Results: Those who received CLA supplementation with equal (50:50) concentrations of the active isomers performed significantly better than those in the control group or the other experimental group. In fact, at the conclusion of the study the antibody level in those who received CLA with c9, t11 and t10, c12 in a 50:50 ratio was twice as high as those who received CLA with those isomers in an 80:20 ratio or those who received no CLA at all.
|Printer friendly Cite/link Email Feedback|
|Article Type:||Brief Article|
|Date:||Sep 1, 2002|
|Previous Article:||Antioxidants. (Raw Material Research).|
|Next Article:||L-carnitine L-tartrate (LCLT). (Raw Material Research).|